Lumida
/CLDX
⌘K
Celldex Therapeutics Inc

Celldex Therapeutics Inc

CLDX
$36.90USD-3.15%-1.20 today

MARKET CAP

2.9B

P/E (TTM)

FWD P/E

DAY RANGE

$37 – $39

52W RANGE

$22
$45

AI Summary

Stalk
Sell NowMedium

CLDX has broken decisively below its key support around 38.8–39.4 in a Stage 3 distribution context, confirming supply dominance. Short-term price is extended below declining EMAs with no exhaustion visible, justifying Sell Now into the broken support–turned–resistance zone for continuation participation.

  • Phase 1 CDX-622 delivered dose-dependent, durable serum tryptase reductions.
  • Two Phase 3 barzolvolimab trial readouts in late 2026 could spark stock gains.
  • Profitability remains deeply negative, highlighting ongoing net losses.
Full analysis →

Buying

6

institutions

Selling

9

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY7.00 M260.56 M+1.63 M+53.0%0.00%
EP

Eversept Partners, LP

Q2 2026

SELL1.79 M66.45 M+-2.08 K+17.2%3.45%
MM

Millennium Management LLC

Q2 2026

SELL1.17 M43.56 M+-82.75 K+9.6%0.02%
FA

Fisher Asset Management, LLC

Q2 2026

SELL985.68 K36.68 M+-27.97 K+14.1%0.01%
WP

Woodline Partners LP

Q2 2026

SELL700.83 K26.08 M+-299.42 K-17.8%0.08%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY619.54 K23.05 M+191.73 K+69.9%1.06%
JC

Jpmorgan Chase & Co

Q2 2026

SELL157.24 K6.00 M+-7.54 K+23.5%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL119.42 K4.44 M+-3.11 M-95.7%0.01%
AC

Aqr Capital Management LLC

Q2 2026

BUY86.89 K3.23 M+79.12 K+1210.7%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW63.50 K2.36 M+63.50 K+0.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL57.90 K2.15 M+-185.01 K-72.0%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY51.28 K1.63 M+25.64 K+133.5%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL26.31 K979.11 K+-58.71 K-63.7%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL8.13 K302.56 K+-1.12 K+3.1%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY1.30 K48.22 K+145.00+32.1%0.00%